Compare ESLA & PRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ESLA | PRT |
|---|---|---|
| Founded | 2021 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.0M | 29.6M |
| IPO Year | 2021 | N/A |
| Metric | ESLA | PRT |
|---|---|---|
| Price | $0.73 | $2.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | 23.6K | ★ 25.1K |
| Earning Date | 05-26-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 13.45% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.78 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.68 | $1.82 |
| 52 Week High | $3.15 | $4.12 |
| Indicator | ESLA | PRT |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 53.52 |
| Support Level | N/A | $2.02 |
| Resistance Level | N/A | $2.34 |
| Average True Range (ATR) | 0.00 | 0.07 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 55.56 |
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.